Commentary: quality improvement projects: how do we protect patients' rights?

Area of Science:

• Medical Ethics
• Health Services Research
• Regulatory Science

Background:

• A recent ruling by the Office of Human Research Protection (OHRP) has reignited the debate on Institutional Review Board (IRB) oversight for quality improvement projects (QIPs).
• Distinguishing between clinical practice, QIPs, and clinical research is crucial for appropriate oversight and accountability.
• Ethical considerations, including patient safety, privacy, and self-determination, are central to this discussion.

Purpose of the Study:

• To analyze the similarities and differences between clinical practice, QIPs, and clinical research.
• To identify key issues in determining the most suitable oversight and accountability mechanisms for QIPs.
• To propose a framework for ensuring ethical conduct and patient protection in QIPs.

Main Methods:

• Comparative analysis of clinical practice, QIPs, and clinical research.
• Examination of ethical principles relevant to human subjects research and quality improvement.
• Review of regulatory guidance from the Office of Human Research Protection (OHRP).

Main Results:

• QIPs share characteristics with both clinical practice and clinical research.
• The goals of QIPs (administrative vs. clinical improvement) impact individual patients and populations differently.
• Current oversight structures may not adequately address the ethical complexities of QIPs.

Conclusions:

• Quality Improvement Projects (QIPs) warrant a dedicated oversight system due to their hybrid nature.
• Proposed solutions include establishing institutional or regional quality improvement boards.
• These boards would operate parallel to IRBs, ensuring equivalent protections for QIP participants as those in clinical research.